Little evidence for long-term harm from antenatal corticosteroids in a population-based very low birthweight young adult cohort.

In this population-based VLBW cohort, we detected minimal adverse outcomes associated with exposure to ACS by the third decade of life, a similar result to the 30-year follow-up of participants in the first ACS trial. However, further follow-up is warranted.